IDiyas

For the Inventor, By the Inventor

Takatsuki, Japan

Hirohisa Wakatsuka

USPTO Granted Patents = 12

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 73(Granted Patents)


Location History:

  • Takatsuki, JA (1976 - 1977)
  • Takatsuki, JP (1979 - 1988)
  • Osaka, JP (1994 - 1998)

Company Filing History:

goldMedal11 out of 574 
 
Ono Pharmaceutical Co., Ltd.
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 1976-1998

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5733927 - Salts of glucopyranose derivative and solutions of the same (1998-03-31),
2. 5359121 - Glycine derivative monosodium salt tetrahydrate (1994-10-25),
3. 5294723 - Salts of glucopyranose derivatives and its intermediate (1994-03-15),
4. 4783480 - 6-keto-prostaglandin E.sub.1 derivatives (1988-11-08),
5. 4562204 - Trans-.DELTA..sup.2 -prostaglandin D derivatives, process for their (1985-12-31),
6. 4399147 - Prostaglandin 12 analogues and their pharmaceutical compositions (1983-08-16),
7. 4367237 - Prostacyclin analogues (1983-01-04),
8. 4313954 - 6,9-Nitrilo-prostaglandin analogues (1982-02-02),
9. 4178367 - Prostaglandin I.sub.2 analogues (1979-12-11),
10. 4052512 - Prostaglandin analogues (1977-10-04),
11. 4024174 - Tranes-delta 2-prostaglandins (1977-05-17),
12. 3931296 - Trans-.DELTA..sup.2 -prostaglandins (1976-01-06),

Title: Hirohisa Wakatsuka: Innovator in Pharmaceutical Chemistry

Introduction

Hirohisa Wakatsuka is a prominent inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 12 patents. His work focuses on enhancing cellular immunity and developing compounds with therapeutic potential.

Latest Patents

Wakatsuka's latest patents include innovative compounds that demonstrate enhanced activity for cellular immunity. One notable patent is for salts of glucopyranose derivative and solutions of the same. This method improves the solubility of a glucopyranose derivative, which possesses enhanced activity for cellular immunity and is useful as an anti-tumor agent. Another significant patent is for a glycine derivative monosodium salt tetrahydrate, which is a stable compound with an inhibitory effect on elastase. This compound may be beneficial in treating diseases caused by the abnormal degradation of elastin and collagen fibers.

Career Highlights

Throughout his career, Hirohisa Wakatsuka has worked with notable companies, including Ono Pharmaceutical Co., Ltd. His expertise in pharmaceutical chemistry has led to the development of innovative solutions that address critical health issues.

Collaborations

Wakatsuka has collaborated with esteemed colleagues such as Masaki Hayashi and Yoshitaka Konishi. These partnerships have contributed to the advancement of research and development in the pharmaceutical field.

Conclusion

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…